Cargando…
Systemic Sclerosis, Reversible Cerebral Vasoconstriction Syndrome, and NeuroMyelitis Optica in a Patient
Systemic sclerosis (SSC) is an autoimmune disease of connective tissue and microvasculature mostly caused by autoantibodies. Likewise, neuromyelitis optica (NMO) is a demyelinating disease of the central nervous system correlating with autoantibodies against aquapourin-4. Reversible cerebral vasocon...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296349/ https://www.ncbi.nlm.nih.gov/pubmed/35864935 http://dx.doi.org/10.1155/2022/8541329 |
_version_ | 1784750254710587392 |
---|---|
author | Etemadifar, Masoud Shafiei, Mehdi Salari, Mehri Modares Sadeghi, Ali Fakhrolmobasheri, Mohammad |
author_facet | Etemadifar, Masoud Shafiei, Mehdi Salari, Mehri Modares Sadeghi, Ali Fakhrolmobasheri, Mohammad |
author_sort | Etemadifar, Masoud |
collection | PubMed |
description | Systemic sclerosis (SSC) is an autoimmune disease of connective tissue and microvasculature mostly caused by autoantibodies. Likewise, neuromyelitis optica (NMO) is a demyelinating disease of the central nervous system correlating with autoantibodies against aquapourin-4. Reversible cerebral vasoconstriction syndrome (RCVS) is a disorder of brain vasculature resembling Raynaud phenomena in SSC. Despite co-occurrence is not rare in autoimmune disorders, the co-occurrence of NMO and SSC is extremely rare. In this case, we report a 35-year-old female presenting with paraplegia one day after discharge from hospital following surgical carnioplasty. She had a history of scleroderma and optic neuritis for which she was treated with high dose glucocorticoids causing renal crisis and RCVS causing intracranial and intracerebral hemorrhage which required a craniotomy to be performed in February 2020. In her recent admission, magnetic resonance imaging of the spinal cord indicated longitudinally extensive transverse myelitis (LETM) and blood tests revealed a highly positive titer of NMO-IgG. Daily plasmapheresis resulted in satisfactory improvement in her condition. This case highlights the importance of evaluating neurologic manifestations in systemic sclerosis patients considering the NMO and RCVS occurrence. Additionally, in concomitant cases, the treatment strategy should be modified regarding the risk of scleroderma renal crisis. |
format | Online Article Text |
id | pubmed-9296349 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-92963492022-07-20 Systemic Sclerosis, Reversible Cerebral Vasoconstriction Syndrome, and NeuroMyelitis Optica in a Patient Etemadifar, Masoud Shafiei, Mehdi Salari, Mehri Modares Sadeghi, Ali Fakhrolmobasheri, Mohammad Case Reports Immunol Case Report Systemic sclerosis (SSC) is an autoimmune disease of connective tissue and microvasculature mostly caused by autoantibodies. Likewise, neuromyelitis optica (NMO) is a demyelinating disease of the central nervous system correlating with autoantibodies against aquapourin-4. Reversible cerebral vasoconstriction syndrome (RCVS) is a disorder of brain vasculature resembling Raynaud phenomena in SSC. Despite co-occurrence is not rare in autoimmune disorders, the co-occurrence of NMO and SSC is extremely rare. In this case, we report a 35-year-old female presenting with paraplegia one day after discharge from hospital following surgical carnioplasty. She had a history of scleroderma and optic neuritis for which she was treated with high dose glucocorticoids causing renal crisis and RCVS causing intracranial and intracerebral hemorrhage which required a craniotomy to be performed in February 2020. In her recent admission, magnetic resonance imaging of the spinal cord indicated longitudinally extensive transverse myelitis (LETM) and blood tests revealed a highly positive titer of NMO-IgG. Daily plasmapheresis resulted in satisfactory improvement in her condition. This case highlights the importance of evaluating neurologic manifestations in systemic sclerosis patients considering the NMO and RCVS occurrence. Additionally, in concomitant cases, the treatment strategy should be modified regarding the risk of scleroderma renal crisis. Hindawi 2022-07-12 /pmc/articles/PMC9296349/ /pubmed/35864935 http://dx.doi.org/10.1155/2022/8541329 Text en Copyright © 2022 Masoud Etemadifar et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Etemadifar, Masoud Shafiei, Mehdi Salari, Mehri Modares Sadeghi, Ali Fakhrolmobasheri, Mohammad Systemic Sclerosis, Reversible Cerebral Vasoconstriction Syndrome, and NeuroMyelitis Optica in a Patient |
title | Systemic Sclerosis, Reversible Cerebral Vasoconstriction Syndrome, and NeuroMyelitis Optica in a Patient |
title_full | Systemic Sclerosis, Reversible Cerebral Vasoconstriction Syndrome, and NeuroMyelitis Optica in a Patient |
title_fullStr | Systemic Sclerosis, Reversible Cerebral Vasoconstriction Syndrome, and NeuroMyelitis Optica in a Patient |
title_full_unstemmed | Systemic Sclerosis, Reversible Cerebral Vasoconstriction Syndrome, and NeuroMyelitis Optica in a Patient |
title_short | Systemic Sclerosis, Reversible Cerebral Vasoconstriction Syndrome, and NeuroMyelitis Optica in a Patient |
title_sort | systemic sclerosis, reversible cerebral vasoconstriction syndrome, and neuromyelitis optica in a patient |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296349/ https://www.ncbi.nlm.nih.gov/pubmed/35864935 http://dx.doi.org/10.1155/2022/8541329 |
work_keys_str_mv | AT etemadifarmasoud systemicsclerosisreversiblecerebralvasoconstrictionsyndromeandneuromyelitisopticainapatient AT shafieimehdi systemicsclerosisreversiblecerebralvasoconstrictionsyndromeandneuromyelitisopticainapatient AT salarimehri systemicsclerosisreversiblecerebralvasoconstrictionsyndromeandneuromyelitisopticainapatient AT modaressadeghiali systemicsclerosisreversiblecerebralvasoconstrictionsyndromeandneuromyelitisopticainapatient AT fakhrolmobasherimohammad systemicsclerosisreversiblecerebralvasoconstrictionsyndromeandneuromyelitisopticainapatient |